Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

7 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Susceptibility to mycobacterial infection in VEXAS syndrome.
Riescher S, Lecomte R, Danic G, Graveleau J, Le Bris Y, Hello M, Guillouzouic A, Guardiolle V, Garnier A, Grossi O, Gaborit B, Néel A. Riescher S, et al. Among authors: guardiolle v. Rheumatology (Oxford). 2024 Feb 5:keae087. doi: 10.1093/rheumatology/keae087. Online ahead of print. Rheumatology (Oxford). 2024. PMID: 38317027
Correction to: Real-world multicentre cohort of first-line pembrolizumab alone or in combination with platinum-based chemotherapy in non-small cell lung cancer PD-L1 ≥ 50.
Pons-Tostivint E, Hulo P, Guardiolle V, Bodot L, Rabeau A, Porte M, Hiret S, Demontrond P, Curcio H, Boudoussier A, Veillon R, Mayenga M, Dumenil C, Chatellier T, Gourraud PA, Mazieres J, Bennouna J. Pons-Tostivint E, et al. Among authors: guardiolle v. Cancer Immunol Immunother. 2023 Jun;72(6):1891-1892. doi: 10.1007/s00262-023-03405-7. Cancer Immunol Immunother. 2023. PMID: 36847863 Free PMC article. No abstract available.
Real-world multicentre cohort of first-line pembrolizumab alone or in combination with platinum-based chemotherapy in non-small cell lung cancer PD-L1 ≥ 50.
Pons-Tostivint E, Hulo P, Guardiolle V, Bodot L, Rabeau A, Porte M, Hiret S, Demontrond P, Curcio H, Boudoussier A, Veillon R, Mayenga M, Dumenil C, Chatellier T, Gourraud PA, Mazieres J, Bennouna J. Pons-Tostivint E, et al. Among authors: guardiolle v. Cancer Immunol Immunother. 2023 Jun;72(6):1881-1890. doi: 10.1007/s00262-022-03359-2. Epub 2023 Jan 24. Cancer Immunol Immunother. 2023. PMID: 36690799 Free PMC article.
Seasonal effect on fatigue, pain and dryness in primary Sjögren's syndrome.
Duret PM, Meyer N, Saraux A, Devauchelle-Pensec V, Seror R, Le-Guern V, Larroche C, Perdriger A, Sibilia J, Guardiolle V, Mariette X, Gottenberg JE. Duret PM, et al. Among authors: guardiolle v. Arthritis Res Ther. 2020 Feb 24;22(1):39. doi: 10.1186/s13075-020-2118-1. Arthritis Res Ther. 2020. PMID: 32093783 Free PMC article.